medline.ch Onkologie Urologische Tumoren

	CD39/CD73-mediated immunosuppression and tumor aggressiveness in bladder cancer. Cancer Immunol Immunother Furriel F, Laranjeira P, Pereira M, Silva S, Silva I, Fontinha G, Sousa V, Gomes C, Parada B, Paiva A. PMID: 42018002 [PubMed - as supplied by publisher]
	Clinical Benefit and Safety of Combined Immunotherapy and Targeted Therapy in Prostate Cancer. Int J Cancer Han Z, Yi X, Tang Y, Li X, Liao D, Xu H, Zheng X, Ai J. PMID: 42017392 [PubMed - as supplied by publisher]
	Uncovering novel germline variants associated with testicular germ cell tumors by exome sequencing. NAR Cancer Cuevas-Estrada B, Ríos-Rodríguez JA, García-Pacheco JA, Wegman-Ostrosky T, Cervera A, Alcaraz N, Montalvo-Casimiro M, Barrón-Hernández A, Castro-Hernández C, Jiménez-Ríos MA, Sobrevilla-Moreno N, Arriaga-Canon C, Herrera LA, González-Barrios R. PMID: 42017013 [PubMed - indexed for MEDLINE]
	PSMA-Targeting Macrophage Membrane-Coated Nanoparticles for Precision Diagnosis and Combination Therapy of Prostate Cancer. Exploration (Beijing) Zhang K, Gao B, Wang J, Li Y, Xu C, Yang F, Liu S, Li H, Zhang C, Meng X, Shi Z, Zhang R, Zhang R, Wang Z, Wen W, Zhang Q, Zou Y, Han D, Bian H, Qin W. PMID: 42016765 [PubMed]
	Predicting recurrence of prostate cancer after radical treatment using AI models based on PET/CT radiomics: a dual-center study. Front Oncol Yi Z, Li W, Lou Y, Zhou Q. PMID: 42016705 [PubMed]
	Niraparib With Abiraterone Acetate Plus Prednisone as First-Line Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer With Homologous Recombination Repair Gene Alterations: Final Analysis of the Asian Subgroup From the MAGNITUDE Study. Int J Urol Ye D, Saad M, Lee JY, Jung W, Pang ST, Li L, Gurney H, Attard G, Chi KN, Mundle S, Zhuo J, Singh A, Lin Y, Sandhu S. PMID: 42015879 [PubMed - indexed for MEDLINE]
	Evaluating the Impact of Age on Prostate Cancer Overdiagnosis Using Long-Term Follow-Up From the CAP Randomised Trial. Int J Cancer Brentnall AR, Rebolj M, Sasieni P, Funston G, Gabe R, Vickers AJ. PMID: 42015666 [PubMed - as supplied by publisher]
	Standardized Program of Resistance Training for Prostate Cancer Patients Receiving Androgen Deprivation Therapy (SPoRT-PCa-ADT): study protocol for a randomized controlled trial. BMC Cancer Soler-López A, Gómez-Carmona CD, González-Devesa D, López-Plaza D, Herrero-Vidal L, Toledo-Pozuelo R, González-Costea A, Cao-Avellaneda E. PMID: 42015017 [PubMed - as supplied by publisher]
	Prognostic impact of large cribriform architecture and intraductal carcinoma of the prostate in diagnostic biopsies of mCSPC receiving ARPI-based therapy. Jpn J Clin Oncol Sato S, Urabe F, Imai Y, Iwamoto Y, Iwatani K, Tashiro K, Tsuzuki S, Umemori M, Miki J, Kimura T, Shimoda M, Takahashi H. PMID: 42014352 [PubMed - as supplied by publisher]
	ProHealth: a co-designed online home-based healthy eating and exercise programme for men with prostate cancer treated with androgen deprivation therapy - a study protocol for a feasibility and preliminary efficacy randomised controlled trial. BMJ Open Baguley B, Daly R, Livingston P, Rawstorn J, White V, Koorts H, Fraser S, Gardner J, Atkins L, Steer B, O E, Heneka N, Abbott G, Russell G, McNamara G, Kiss N. PMID: 42014146 [PubMed - indexed for MEDLINE]
	Stereotactic body radiotherapy plus sunitinib vs. sunitinib alone in treatment-naive oligometastatic renal cell carcinoma: A phase 2 clinical trial. Cell Rep Med Liu Y, Zhang XY, Wei WS, Liu RQ, Pan QW, Zhang YJ, Li JB, Peng YL, Huang TX, Zhang ZL, Han H, Guo SJ, Gao JM, Zhou FJ, Dong P, He LR. PMID: 42013852 [PubMed - as supplied by publisher]
	Prognostic Significance of Myopenia, Myosteatosis, and Frailty in Older Patients With Prostate Cancer Undergoing Definitive Radiotherapy. Cancer Control Aksoy RA, Koca T, Çetmi DA, K, Korcum AF. PMID: 42013016 [PubMed - indexed for MEDLINE]
	Prostate Cancer Incidence, Mortality, and Survival in Switzerland. JAMA Netw Open Menges D, Wildisen L, Scherer T, Tancredi S, Würnschimmel C, Sigg S, Hao S, Lippuner M, Cathomas R, Templeton AJ, Chmiel C, Rentsch CA, Eberli D, Kwiatkowski M, Mortezavi A, Chiolero A, Rohrmann S, Clements M, Staehelin K. PMID: 42012828 [PubMed - indexed for MEDLINE]
	Streamlined calculation of kidney function using dynamic contrast-enhanced MRI with population-based arterial input function and a whole-kidney model. Eur Radiol Exp Mu X, Liu MM, Al-Mubarak H, Kennedy P, Robson P, Cuevas J, Kuhn B, Badani K, Taouli B, Lewis S, Bane O. PMID: 42012724 [PubMed - indexed for MEDLINE]
	Habitat-based radiomics-clinical analysis for early prediction of bladder cancer recurrence: a retrospective cohort study. Abdom Radiol (NY) Yang Y, Gong B, Kong X, Guo Y, Lou J, Fu X, Liu W, Feng Q, Yang L. PMID: 42012493 [PubMed - as supplied by publisher]
	The Swedish national guidelines on prostate cancer: recurrent, metastatic and castration resistant disease. Scand J Urol Stranne J, Axen E, Bratt O, Carlsson S, Kindblom J, Kohestani K, Kristiansen A, Franck Lissbrant I, Moise G, Nemlander E, Robinsson D, Torbrand C, Trägårdh E, Wallström J, Wennerberg C, Thellenberg Karlsson C. PMID: 42012147 [PubMed - indexed for MEDLINE]
	Partial versus radical nephrectomy for pT3a renal cell carcinoma: a systematic review and meta-analysis. J Robot Surg Gavi F, Rossi F, Fettucciari D, Pallotta G, Silvestri A, Carerj C, Cavarra V, Sanesi D, Bizzarri FP, Montesi M, Assumma S, Panio E, Russo P, Ragonese M, Foschi N, Turri F, Sighinolfi MC, Rocco B. PMID: 42010212 [PubMed - in process]
	Sexual Health Needs and Physician-Patient Interaction Experiences Among Postoperative Radical Prostatectomy Patients in China: A Qualitative Study. Nurs Open Zhu H, Xu T, Xie J, Wei S, Jin X, Meng Y, Lu X, Zhang H, Zhu Y, Li J. PMID: 42008783 [PubMed - indexed for MEDLINE]
	A Single-Center Study: XGBoost-Based Multi-Omics Prediction Model for Sepsis-Associated Acute Kidney Injury (SA-AKI) and Personalized Immune Therapy Efficacy in Pancreatic Cancer ICU Patients. Shock Long Z, Fu Y, Wang S, Bao Y, Li Y. PMID: 42008769 [PubMed - as supplied by publisher]
	Prognostic and Predictive Value of the Clearseq1-4 Tumor Microenvironment Classification in Localized and Metastatic Clear-Cell Renal Cell Carcinoma. Cancer Res Commun Kinget L, McTaggart ES, Demeulenaere O, Roussel E, Boeckx B, Zucman-Rossi J, Couchy G, Vandermeulen H, De Wever L, Baldewijns M, Wozniak A, Joniau S, Lambrechts D, Naulaerts S, Garg AD, Verbiest A, Albersen M, Beuselinck B. PMID: 42008739 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 177649

Seite 1 von 8883

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung